Citigroup Initiates Coverage On Exact Sciences with Buy Rating, Announces $120 Price Target

Citigroup analyst Patrick Donnelly initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Buy rating and a $120 price target.

Benzinga · 01/07/2020 12:17

Citigroup analyst Patrick Donnelly initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Buy rating and a $120 price target.